Meridian
Pharma & biotech signals

Signals

Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.

Showing 561–580 of 650 signals

Obesity Drugs Show Early Promise Against PMOS

CompaniesChildren's Hospital ColoradoUniversity of Maryland Medical SystemAssetssemaglutideexenatideDiseasespolyendocrine metabolic ovarian syndrome

NICE backs new blood cancer regimens

CompaniesAstraZenecaAssetsacalabrutinibvenetoclaxbendamustinerituximabDiseaseschronic lymphocytic leukaemiamantle cell lymphoma

Lexeo wins FDA RMAT status for LX2020

CompaniesLexeo TherapeuticsAssetsLX2020DiseasesPKP2 arrhythmogenic cardiomyopathy